Methods and tools for prognosis of cancer in her2+ patients

Details Methods and tools for prognosis of cancer in her2+ patients Methods and tools for prognosis of cancer in her2+ patients

C - Chemistry, Metallurgy

12

Q

C12Q 1/68 (2006.01)

Patent

CA 2695814

The present invention is related to a gene or protein set comprising or consisting of at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, and possibly 40, 45, 50, 55, 60, 65 genes or proteins or the entire set selected from the table 12 and/or the table 13, antibodies or hypervariable portion thereof directed against the proteins encoded by these genes.

La présente invention concerne un ensemble de gènes ou de protéines comprenant ou constitué d'au moins 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, et éventuellement de 40, 45, 50, 55, 60, 65 gènes ou protéines ou de l'ensemble entier sélectionné dans le tableau 12 et/ou le tableau 13, d'anticorps ou de partie hypervariable de cet ensemble dirigés contre les protéines codées par ces gènes.

Affiliated with

Also associated with

Rating

Methods and tools for prognosis of cancer in her2+ patients does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and tools for prognosis of cancer in her2+ patients, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and tools for prognosis of cancer in her2+ patients will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1626214